SSC- ILD Management in 2024

In this expert talk on Systemic Sclerosis-Associated Interstitial Lung Disease (SSC ILD) Management, we will explore cutting-edge approaches and evidence-based practices for optimizing patient care. We will discuss recent clinical trials that highlight advancements in early diagnosis and personalized treatment strategies, improving prognostic outcomes. Key topics include the latest antifibrotic pharmacotherapies and their impact on slowing disease progression. We will also address the... Read more